The Endocrine Society is an international body with 13,000 members from over 85 countries.
These professionals are dedicated to researching and treating the full range of endocrine disorders: diabetes, reproduction, infertility, osteoporosis, thyroid disease, obesity/lipids, growth hormone, pituitary tumors, and adrenal insufficiency.
The Endocrine Society works to foster a greater understanding of endocrinology among the general public and practitioners of complementary medical disciplines, and to promote the interests of all endocrinologists at the national scientific research and health policy levels of government.
The Endocrine Society has developed treatment guidelines for men with Low T.
Click here to view these guidelines.
The following resources can give you additional information on Low T.
American Association of Clinical Endocrinologists (AACE)
1000 Riverside Avenue, Suite 205
Jacksonville, FL 32204
904.353.7878
www.aace.com
American Academy of Family Physicians (AAFP)
11400 Tomahawk Creek Parkway
Leawood, KS 66211-2672
913.906.6000
www.aafp.org
The Endocrine Society
8401 Connecticut Avenue, Suite 900
Chevy Chase, MD 20815
301.941.0200 or 888.363.6274
www.endo-society.org
American Association for Klinefelter Syndrome Information and Support (AAKSIS)
2945 W. Farwell Ave.
Chicago, IL 60645-2925
888.466.KSIS (888.466.5747)
www.aaksis.org
American Diabetes Association (ADA)
1701 North Beauregard Street
Alexandria, VA 22311
800.DIABETES (800.342.2383)
www.diabetes.org
INDICATION
- AndroGel® (testosterone gel) is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary Hypogonadism or Hypogonadotropic Hypogonadism.
IMPORTANT SAFETY INFORMATION
WARNING: SECONDARY EXPOSURE TO TESTOSTERONE
- Virilization has been reported in children who were secondarily exposed to testosterone gel.
- Children should avoid contact with any unwashed or unclothed application sites in men using testosterone gel.
- Healthcare providers should advise patients to strictly adhere to recommended instructions for use.
- AndroGel is contraindicated: in men with breast cancer or known or suspected prostate cancer; in women who are pregnant, may become pregnant, or are breastfeeding as testosterone may cause fetal harm; or in men with known hypersensitivity to any of the ingredients in AndroGel, including alcohol and soy products.
- Patients with benign prostatic hyperplasia (BPH) treated with androgens are at increased risk for worsening signs and symptoms of BPH.
- Patients treated with androgens may be at increased risk for prostate cancer.
- Strict adherence to the following precautions is advised in order to minimize the potential for secondary exposure to testosterone from AndroGel-treated skin:
| - | Children and women should avoid contact with unwashed or unclothed application site(s) of men using testosterone gel. |
| - | Patients should wash their hands with soap and water after application. |
| - | Cover the application site with clothing after the gel has dried. |
| - | Wash the application site thoroughly with soap and water prior to any situation where skin-to-skin-contact of the application site with another person is anticipated. |
| - | Do not apply AndroGel to the genitals. |
- Signs of virilization in children and women and the possibility of secondary exposure to testosterone gel should be brought to the attention of the healthcare provider. Testosterone gel should be promptly discontinued until the cause of the virilization is identified.
- AndroGel is not indicated for use in women.
- Treatment with androgens may lead to: azoospermia; edema in patients with preexisting cardiac, renal or hepatic disease; gynecomastia; sleep apnea in those with risk factors; changes in insulin sensitivity or glycemic control; and changes in anticoagulant activity.
- Monitor serum testosterone, prostate-specific antigen, hemoglobin, hematocrit, liver function test, and lipid levels periodically.
- Most common adverse reactions (incidence ≥5%) are acne, application site reactions, abnormal lab tests, and prostatic disorders.
Please see full Prescribing Information including boxed warning and Medication Guide.
